Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Salvage radiation therapy and docetaxel (Taxotere) for biochemical failure after radical prostatectomy

Trial Profile

Salvage radiation therapy and docetaxel (Taxotere) for biochemical failure after radical prostatectomy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Jan 2019

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 02 Dec 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 13 Jul 2012 Planned end date changed from 1 May 2012 to 1 May 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top